Literature DB >> 5428749

Serum creatine kinase levels.

A E Emery, A M Spikesman.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5428749      PMCID: PMC1700802          DOI: 10.1136/bmj.2.5712.790-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination.

Authors:  R Richterich; S Rosin; U Aebi; E Rossi
Journal:  Am J Hum Genet       Date:  1963-06       Impact factor: 11.025

2.  Myopathy and malignant hyperpyrexia.

Authors:  M A Denborough; P Ebeling; J O King; P Zapf
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

3.  The significance of the dilution effect in serum creatine kinase diagnosis of muscular dystrophy.

Authors:  A M Spikesman; D J Brock
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

4.  Evidence against the existence of a subclinical form of X-linked Duchenne muscular dystrophy.

Authors:  A E Emery; A Spikesman
Journal:  J Neurol Sci       Date:  1970-06       Impact factor: 3.181

5.  Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy.

Authors:  H Isaacs; M B Barlow
Journal:  Br Med J       Date:  1970-01-31
  5 in total
  3 in total

1.  The normal range for serum creatine phosphokinase.

Authors:  D McCormick
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

Review 2.  Enzyme assays in diseases of the heart and skeletal muscle.

Authors:  S B Rosalki
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1970

3.  Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening.

Authors:  H Isaacs; M B Barlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.